Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma.

World J Gastrointest Surg · 2021 · PMC8554719 · PMID 34754383

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the primary endpoint (OS) of the nivolumab group did not reach statistical significance, the OS of the nivolumab group was clinically improved, with a high ORR and good tolerance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.